Medically assisted withdrawal (Detoxification): Considering the mother-infant dyad

Journal of Addiction Medicine

Volumn 11, Issue 2, 2017, Pages 90-92

  Jones, Hendrée E ^a,b   Terplan, Mishka ^c   Meyer, Marjorie ^d  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Child and Adolescent Services   (United States)

^d UNIVERSITY OF VERMONT   (United States)

Author keywords

fetus; neonatal abstinence syndrome; neonate; opioid use disorder; pregnancy

Indexed keywords

OPIATE AGONIST;

BEHAVIOR THERAPY; CHRONIC DISEASE; CLINICAL EFFECTIVENESS; DRUG DETOXIFICATION; FETUS DEATH; FOLLOW UP; HUMAN; INFANT; MATERNAL DISEASE; MEDICALLY ASSISTED WITHDRAWAL; MOTHER CHILD RELATION; MOTHER FETUS RELATIONSHIP; NEONATAL ABSTINENCE SYNDROME; OPIATE ADDICTION; PATIENT SAFETY; PREGNANCY; RECURRENCE RISK; RELAPSE; REVIEW; RISK ASSESSMENT; THERAPY EFFECT; ADULT; FEMALE; NEWBORN; OPIOID-RELATED DISORDERS; OUTCOME ASSESSMENT; PREGNANCY COMPLICATIONS; WITHDRAWAL SYNDROME;

ADULT; FEMALE; HUMANS; INFANT, NEWBORN; NEONATAL ABSTINENCE SYNDROME; OPIOID-RELATED DISORDERS; OUTCOME ASSESSMENT (HEALTH CARE); PREGNANCY; PREGNANCY COMPLICATIONS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 85015878238     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0000000000000289     Document Type: Review

References (16)

1. Bell J, Towers CV, Hennessy MD, et al. Detoxification from opiate drugs during pregnancy. Am J Obstet Gynecol 2016;215:374.e1-6.
2. Center for Substance Abuse Treatment. Detoxification and Substance Abuse Treatment. Treatment Improvement Protocol (TIP) Series, No. 45. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2006.
3. Cleveland LM, Bonugli R. Experiences of mothers of infants with neonatal abstinence syndrome in the neonatal intensive care unit. J Obstet Gynecol Neonatal Nurs 2014;43:318-329.
4. Dashe JS, Jackson GL, Olscher DA, et al. Opioid detoxification in pregnancy. Obstet Gynecol 1988;92:854-858.
5. Duvall HJ, Locke BZ, Brill L. Followup study of narcotic drug addicts five years after hospitalization. Public Health Rep 1963;78:185-194.
6. Hunt GH, Odoroff ME. Followup study of narcotic drug addicts after hospitalization. Public Health Rep 1962;77:41-54.
7. Jones HE, Chisolm MS, Jansson LM, et al. Naltrexone in the treatment of opioid-dependent pregnant women: common ground. Addiction 2013;108: 255-256.
8. Jones HE, OGrady KE, Malfi D, et al. Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes. Am J Addict 2008;17:372-386.
9. Kaltenbach K, Jones HE. Neonatal abstinence syndrome: presentation and treatment considerations. J Addict Med 2016;10:217-222.
10. Lund IO, Fitzsimons H, Tuten M, et al. Comparing methadone and buprenorphine maintenance with methadone-assisted withdrawal for the treatment of opioid dependence during pregnancy: maternal and neonatal outcomes. Subst Abuse Rehabil 2012;3(Suppl 1):17-25.
11. Luty J, Nikolaou V, Bearn J. Is opiate detoxification unsafe in pregnancy? J Subst Abuse Treat 2003;24:363-367.
12. Patrick SW, Dudley J, Martin PR, et al. Prescription opioid epidemic and infant outcomes. Pediatrics 2015;135:842-850.
13. Rementeria JL, Nunag NN. Narcotic withdrawal in pregnancy: stillbirth incidence with a case report. Am J Obstet Gynecol 1973;116:1152-1156.
14. Sarfi M, Smith L, Waal H, et al. Risks and realities: dyadic interaction between 6-month-old infants and their mothers in opioid maintenance treatment. Infant Behav Dev 2011;34:578-589.
15. Stewart RD, Nelson DB, Adhikari EH, et al. The obstetrical and neonatal impact of maternal opioid detoxification in pregnancy. Am J Obstet Gynecol 2013;209:267.e261-265.e261.
16. Zuspan FP, Gumpel JA, Mejia-Zelaya A, et al. Fetal stress from methadone withdrawal. Am J Obstet Gynecol 1975;122:43-46.